We are happy to announce that Brittany region continue to help us (article in french) and co-funds one of our R&D projects in collaboration with Dr Anne Corlu, head of team 2 and Dr Bernard Fromenty, head of team 3 of UMR991 directed by Dr Bruno Clément in Rennes. Our R&D projects have two goals :

  • To develop new hepatotoxicity assays as steatosis, phospholipidosis, NASH… in 3D to order to mimic at best in situ situation
  • To undestand the implication of the microenvironnement in hepatocarcinoma development and thus to develop new assays in order to found new drugs to treat this disease

We really want to thanks Brittany region for its support and we are happy to work in collaboration with researchers in Rennes recognised in their work. Thank you also to id2sante for their help in this project.


4 Comments

3D culture market and InnovCell 3D | HCS-pharma · September 2, 2016 at 9:01 am

[…] models to increase in vitro predictions and understanding of liver diseases. We like to thanks Brittany region who fund this project, and participate to the development of new 3D models in cell biology. In this project, We work also […]

Goodbye 2016, welcome 2017 ! | HCS-pharma · March 16, 2017 at 10:02 am

[…] team, the effective launch of partnerships with the “Insitut du Thorax” in Nantes and Inserm U991 in Rennes, and customers partners that reiterate their trust. 2017 will be the year of our strengthening, […]

A great Molecular Devices user meeting in Cambridge ! | HCS-pharma · May 21, 2017 at 7:25 pm

[…] a short presentation of our services, we explained our implication in the two research projects InnovCell 3D and Chopin. Many people were interested by these […]

Imaging 3D spheroïds with light sheet microscopy | HCS-pharma · July 21, 2017 at 9:20 am

[…] from Imagin Optics, we had the opportunity to use the SPIM microscope. Dr Savary, our partner in Innovcell 3D project, join us with hepatocytes spheroïds prepared for […]

Leave a Reply